Alpha interferon: new associations in haematology/oncology. The Montpellier experience

In vitro Activation of B-CLL Cells.

Leukemia & lymphoma·2016

A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation.

Leukemia·2010

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.

Oncogene·2009

Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients.

Bone marrow transplantation·2006

Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma.

Oncology·2005

Cyclooxygenase-2 selective inhibitors in cancer prevention and therapy: inflammopharmacological basis and translational prospects.

Medical oncology (Northwood, London, England)·2026

OLR1 drives gastric cancer progression through NF-κB activation and immunosuppressive macrophage polarization.

Medical oncology (Northwood, London, England)·2026

p-Coumaric acid inhibits hepatocellular carcinoma through promoting ROS accumulation.

Medical oncology (Northwood, London, England)·2026

IGF2BP3 enhances paclitaxel resistance in bladder urothelial carcinoma by recognizing m6A-modified CENPA mRNA.

Medical oncology (Northwood, London, England)·2026

Beyond KRASG12C: emerging therapeutic strategies, patent landscape, and clinical progress in targeting KRAS-mutant cancers.

Medical oncology (Northwood, London, England)·2026

From pumps to networks: ABC transporters in leukemia resistance and microenvironmental adaptation.

Medical oncology (Northwood, London, England)·2026

Global research trends in fecal microbiota transplantation combined with immune checkpoint inhibitors for cancer immunotherapy: a bibliometric analysis.

Translational cancer research·2026

Development and clinical implementation of a local automated kidney allocation platform integrating virtual crossmatch.

Frontiers in immunology·2026

Immunometabolic Reprogramming as a Therapeutic Platform: Integrating Systems Immunology with Precision Biopharmaceutical Engineering.

Immunological investigations·2026

[Perioperative Breast Cancer Treatment with Immune Checkpoint Inhibitors-Current Status and Future Perspectives].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Incidence and Predictors of Immune-Related Hypothyroidism Under Pembrolizumab Across Gynecologic Malignancies and Melanoma: A Real-World Cohort Study.

International journal of cancer·2026

Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

Bone marrow transplantation·2026

Related Experiment Videos

Alpha interferon: new associations in haematology/oncology. The Montpellier experience

Related Concept Videos

In vitro Activation of B-CLL Cells.

A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma.

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation.

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.

Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients.

Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma.

Cyclooxygenase-2 selective inhibitors in cancer prevention and therapy: inflammopharmacological basis and translational prospects.

OLR1 drives gastric cancer progression through NF-κB activation and immunosuppressive macrophage polarization.

p-Coumaric acid inhibits hepatocellular carcinoma through promoting ROS accumulation.

IGF2BP3 enhances paclitaxel resistance in bladder urothelial carcinoma by recognizing m6A-modified CENPA mRNA.

Beyond KRASG12C: emerging therapeutic strategies, patent landscape, and clinical progress in targeting KRAS-mutant cancers.

From pumps to networks: ABC transporters in leukemia resistance and microenvironmental adaptation.

Global research trends in fecal microbiota transplantation combined with immune checkpoint inhibitors for cancer immunotherapy: a bibliometric analysis.

Development and clinical implementation of a local automated kidney allocation platform integrating virtual crossmatch.

Immunometabolic Reprogramming as a Therapeutic Platform: Integrating Systems Immunology with Precision Biopharmaceutical Engineering.

[Perioperative Breast Cancer Treatment with Immune Checkpoint Inhibitors-Current Status and Future Perspectives].

Incidence and Predictors of Immune-Related Hypothyroidism Under Pembrolizumab Across Gynecologic Malignancies and Melanoma: A Real-World Cohort Study.

Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

Related Experiment Videos

Alpha interferon: new associations in haematology/oncology. The Montpellier experience

Related Concept Videos

Related Articles